These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27009440)

  • 1. Persistent Mycobacterium abscessus infection secondary to interferon-γ autoantibodies.
    Naik R; Cortes JA
    Ann Allergy Asthma Immunol; 2016 May; 116(5):461-2. PubMed ID: 27009440
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
    Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
    Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
    Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
    BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
    Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
    Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
    Browne SK; Zaman R; Sampaio EP; Jutivorakool K; Rosen LB; Ding L; Pancholi MJ; Yang LM; Priel DL; Uzel G; Freeman AF; Hayes CE; Baxter R; Cohen SH; Holland SM
    Blood; 2012 Apr; 119(17):3933-9. PubMed ID: 22403254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
    Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
    J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
    Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
    Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
    Rujirachun P; Sangwongwanich J; Chayakulkeeree M
    BMC Infect Dis; 2020 Mar; 20(1):232. PubMed ID: 32188404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.
    Koizumi Y; Sakagami T; Nishiyama N; Hirai J; Hayashi Y; Asai N; Yamagishi Y; Kato H; Hagihara M; Sakanashi D; Suematsu H; Ogawa K; Mikamo H
    J Clin Immunol; 2017 Oct; 37(7):644-649. PubMed ID: 28779413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated
    Chetchotisakd P; Anunnatsiri S; Nanagara R; Nithichanon A; Lertmemongkolchai G
    J Immunol Res; 2018; 2018():6473629. PubMed ID: 30687765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection.
    Ogawa Y; Hasebe R; Ohnuma T; Sano S; Mitsui H; Shimada S; Ishihara H; Sakagami T; Kawamura T
    Eur J Dermatol; 2019 Jun; 29(3):339-341. PubMed ID: 31251217
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
    Tanimizu M; Mizuno K; Hashimoto M
    Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DISSEMINATED NONTUBERCULOUS MYCOBACTERIOSIS THAT IS POSITIVE FOR NEUTRALIZING ANTI-INTERFERON-GAMMA AUTOANTIBODIES: A NEW DISEASE CONCEPT BASED ON HOST FACTORS].
    Sakagami T
    Kekkaku; 2015 Jun; 90(6):561-4. PubMed ID: 26489159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated non-tuberculous mycobacterial infection caused by anti-interferon-γ autoantibodies in a patient of very advanced age.
    Yamada T; Iwakami SI; Hara SAM; Iwakami N; Nakamura A; Suzuki Y; Sasaki SI; Takahashi K
    Geriatr Gerontol Int; 2018 Jul; 18(7):1132-1133. PubMed ID: 30133967
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralizing Anti-Interferon-Gamma Autoantibody Levels May Not Correlate With Clinical Course of Disease.
    Tham EH; Huang CH; Soh JY; Thayalasingam M; Lee AJ; Lum LH; Poon LM; Lye DC; Chai LY; Tambyah PA; Lee BW; Shek LP
    Clin Infect Dis; 2016 Aug; 63(4):572-3. PubMed ID: 27225240
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary Mycobacterium fortuitum infection with cervical lymphadenitis in a patient carrying autoantibodies to interferon-γ.
    Suzuki K; Terada J; Sasaki Y; Kawasaki T; Naito Y; Sakurai T; Tanabe N; Tatsumi K
    Intern Med; 2014; 53(12):1361-4. PubMed ID: 24930658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated
    Chaononghin S; Visuttichaikit S; Apisarnthanarak A; Khawcharoenporn T
    Int J Mycobacteriol; 2020; 9(1):91-94. PubMed ID: 32474495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.